Sale!

COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the COL1A2 gene responsible for osteogenesis imperfecta, commonly known as brittle bone disease. This comprehensive test utilizes next-generation sequencing technology to provide detailed analysis of genetic variations that affect collagen production and bone strength. The test is essential for individuals with family history of bone fragility, recurrent fractures, or clinical symptoms of osteogenesis imperfecta. Results help guide treatment decisions, inform family planning, and provide crucial genetic counseling information. The test costs $500 USD and delivers results within 3-4 weeks using blood, extracted DNA, or blood spot samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test

Comprehensive Genetic Testing for Brittle Bone Disease

The COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals and families affected by brittle bone disease. This advanced testing methodology provides crucial insights into the genetic basis of osteogenesis imperfecta, enabling accurate diagnosis, personalized treatment planning, and informed family decisions.

What is Osteogenesis Imperfecta?

Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones that break easily, often with little or no apparent cause. The condition results from mutations in genes responsible for collagen production, particularly the COL1A2 gene, which plays a vital role in bone strength and structural integrity.

What the Test Measures and Detects

Our COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test utilizes next-generation sequencing technology to comprehensively analyze the COL1A2 gene for pathogenic variants. The test specifically detects:

  • Point mutations affecting collagen type I alpha 2 chain production
  • Frameshift mutations disrupting normal protein structure
  • Nonsense mutations leading to premature termination of collagen synthesis
  • Missense mutations altering collagen triple helix formation
  • Splice site mutations affecting mRNA processing

Advanced NGS Technology

Next-generation sequencing provides unparalleled accuracy in detecting genetic variations, offering comprehensive coverage of the entire COL1A2 gene with high sensitivity and specificity. This technology enables the identification of both common and rare mutations that contribute to osteogenesis imperfecta spectrum disorders.

Who Should Consider This Test

This genetic test is recommended for individuals presenting with the following symptoms or risk factors:

  • Recurrent bone fractures with minimal trauma
  • Family history of osteogenesis imperfecta or brittle bone disease
  • Blue sclerae (whites of the eyes)
  • Dentinogenesis imperfecta (discolored, fragile teeth)
  • Hearing loss beginning in early adulthood
  • Short stature and bone deformities
  • Loose joints and muscle weakness
  • Curvature of the spine (scoliosis)
  • Respiratory problems due to chest wall deformities

Family Planning Considerations

Couples with a family history of osteogenesis imperfecta should consider genetic testing to understand their risk of passing the condition to their children. The test provides valuable information for reproductive decision-making and prenatal diagnosis options.

Benefits of Taking the COL1A2 Genetic Test

Undergoing genetic testing for osteogenesis imperfecta offers numerous advantages for patients and their families:

  • Accurate Diagnosis: Confirms or rules out genetic causes of bone fragility
  • Personalized Treatment: Guides appropriate medical management and fracture prevention strategies
  • Family Risk Assessment: Identifies inheritance patterns and risk to other family members
  • Reproductive Planning: Informs decisions about family planning and prenatal testing options
  • Early Intervention: Enables proactive management to prevent complications
  • Psychological Relief: Provides clarity and reduces uncertainty about the condition
  • Research Contribution: Helps advance understanding of osteogenesis imperfecta

Understanding Your Test Results

Positive Result Interpretation

A positive result indicates the presence of a pathogenic mutation in the COL1A2 gene. This confirms the genetic diagnosis of osteogenesis imperfecta and provides information about:

  • Specific mutation type and its clinical implications
  • Expected disease severity and progression
  • Inheritance pattern (autosomal dominant in most cases)
  • Risk to other family members
  • Recommended management and surveillance strategies

Negative Result Interpretation

A negative result means no pathogenic mutations were detected in the COL1A2 gene. However, this does not completely rule out osteogenesis imperfecta, as:

  • Mutations may be present in other collagen-related genes
  • Some genetic variations may not be detectable by current methods
  • Clinical evaluation remains essential for diagnosis

Variant of Uncertain Significance

Sometimes, the test identifies genetic changes whose clinical significance is unknown. In such cases, additional family studies and clinical correlation are recommended to determine the variant’s importance.

Test Pricing and Details

Test Component Price (USD)
COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test – Discount Price $500
COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test – Regular Price $700

Additional Test Information

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Specialty: Dermatology, Genetics, Osteology
  • Method: Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before undergoing the COL1A2 Gene Osteogenesis Imperfecta NGS Genetic DNA Test, patients should provide:

  • Complete clinical history including fracture patterns and bone density measurements
  • Genetic counseling session to discuss testing implications and create a family pedigree chart
  • Informed consent understanding the benefits, limitations, and potential outcomes of testing

Nationwide Testing Availability

We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and healthcare professionals ensures you receive comprehensive support throughout the testing process.

Take Control of Your Genetic Health

Don’t let uncertainty about osteogenesis imperfecta affect your quality of life. Our COL1A2 genetic test provides the clarity you need to make informed healthcare decisions and manage your condition effectively. With advanced NGS technology and expert interpretation, you can trust our results to guide your treatment journey.

Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our genetic specialists are available to answer your questions and help you take the next step toward understanding your genetic health.